Chikungunya Vaccine, Live (IXCHIQ)
Chikungunya Vaccine, Live is an FDA-licensed reference biologic from Valneva Austria GmbH. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2023
Reference approved
Reference product
IXCHIQ Chikungunya Vaccine, Live
Valneva Austria GmbH
- Approved
- Nov 09, 2023
- Marketing
- Disc
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Chikungunya Vaccine, Live, in chronological order.
Reference approval
Approval date of the reference Chikungunya Vaccine, Live product.
2 yr 7 mo ago
Frequently asked questions
Are there biosimilars approved for Chikungunya Vaccine, Live (IXCHIQ)?
No 351(k) biosimilars or interchangeable biosimilars referencing Chikungunya Vaccine, Live are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.